CAN WE USE PREOPERATIVE PSA KINETICS TO PREDICT PATHOLOGIC UPGRADING IN CONTEMPORARY PATIENTS DIAGNOSED WITH GLEASON 6 PROSTATE CANCER?

被引：0
|
作者：
Krane, Louis S.
Kaul, Sanjeev
Siddiqui, Sameer
Bhandari, Mahendra
Peabody, James O.
Menon, Mani
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)60166-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
152
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [41] Does Low PSA Predict for Worse Outcome in Patients With Gleason 8-10 Localized Prostate Cancer Treated With Radiation Therapy?
    Gewanter, R. M.
    Fidaleo, A.
    Pei, X.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S377 - S377
  • [42] Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?
    Li-Jen Kuo
    Jeng-Fong Chiou
    Cheng-Jeng Tai
    Chun-Chao Chang
    Ching-Huei Kung
    Sey-En Lin
    Chin-Sheng Hung
    Weu Wang
    Ka-Wai Tam
    Hung-Chia Lee
    Hung-Hua Liang
    Yu-Jia Chang
    Po-Li Wei
    International Journal of Colorectal Disease, 2012, 27 : 613 - 621
  • [43] A whole blood RNA transcript-based model to predict biopsy Gleason score in newly diagnosed prostate cancer patients
    Oh, W.
    Magidson, J.
    Bankaitis-Davis, D.
    Siconolfi, L.
    Schurko, B.
    Cantu, R.
    Braitsch, S.
    Wassman, K.
    Kantoff, P.
    Ross, R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 27 - 27
  • [44] Prostate Health Index (phi) and its derivatives predict Gleason score upgrading after radical prostatectomy among patients with low-risk prostate cancer
    Yan, Jia-Qi
    Huang, Da
    Huang, Jing-Yi
    Ruan, Xiao-Hao
    Lin, Xiao-Ling
    Fang, Zu-Jun
    Gao, Yi
    Jiang, Hao-Wen
    Wu, Yi-Shuo
    Na, Rong
    Xu, Dan-Feng
    ASIAN JOURNAL OF ANDROLOGY, 2022, 24 (04) : 406 - +
  • [45] Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities
    Leyh-Bannurah, Sami-Ramzi
    Abou-Haidar, Hiba
    Dell'Oglio, Paolo
    Schiffmann, Jonas
    Tian, Zhe
    Heinzer, Hans
    Huland, Hartwig
    Graefen, Markus
    Budaeus, Lars
    Karakiewicz, Pierre I.
    BJU INTERNATIONAL, 2017, 119 (05) : 692 - 699
  • [46] Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era
    Ung, JO
    Richie, JP
    Chen, MH
    Renshaw, AA
    D'Amico, AV
    UROLOGY, 2002, 60 (03) : 458 - 463
  • [47] Use of a surgically derived nomogram to predict high likelihood of Gleason score upgrading for favorable-risk prostate cancer treated with permanent seed brachytherapy
    Bowes, D.
    Crook, J. M.
    Wallace, K.
    Evans, A.
    Toi, A.
    Finelli, A.
    Jewett, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [48] Using PSA Kinetics to Predict 5-yr Biochemical Failure in Intermediate-Risk Prostate Cancer Patients
    McMullan, T.
    Nailon, B.
    McLaren, D.
    Keough, W.
    Law, A.
    Berger, T.
    Ronaldson, T.
    Mitchell, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S193 - S194
  • [49] Updated nomogram to predict pathologic stage of prostate cancer given PSA, clinical stage, and biopsy gleason score (partin tables) based on cases from 2000-2005
    Makarov, Danil V.
    Trock, Bruce J.
    Humphreys, Elizabeth B.
    Mangold, Lesie A.
    Walsh, Patrick C.
    Epstein, Jonathan I.
    Partin, Alan W.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 112 - 112
  • [50] PREDICTION OF OUTCOMES AFTER RADICAL PROSTATECTOMY IN PATIENTS DIAGNOSED WITH PROSTATE CANCER OF BIOPSY GLEASON SCORE ≥ 8 VIA CONTEMPORARY MULTI(≥12)-CORE PROSTATE BIOPSY
    Loeb, Stacy
    BJU INTERNATIONAL, 2011, 108 (02) : 222 - 222
12345